Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Isabelle Aerts

Showing results (51-60 of 123) with videos related to

Pageof 13
Sort By:
Human Molecular Genetics|May 27, 2014
The survival gene MED4 explains low penetrance retinoblastoma in patients with large RB1 deletionCatherine Dehainault, Alexandra Garancher, Laurent Castéra, et al.
European Journal of Medical Genetics|July 22, 2018
Correlation between RB1germline mutations and second primary malignancies in hereditary retinoblastoma patients treated with external beam radiotherapyAmélie Chaussade, Gaël Millot, Constance Wells, et al.
Pediatric Blood & Cancer|July 4, 2020
Tumor rupture in hepatoblastoma: A high risk factor?Morgane Pondrom, Daniele Pariente, Brenda Mallon, et al.
Frontiers in Pediatrics|June 9, 2023
A phase 1, first-in-child, multicenter study to evaluate the safety and efficacy of the oncolytic herpes virus talimogene laherparepvec in pediatric patients with advanced solid tumorsLucas Moreno, Pierre Teira, James M Croop, et al.
Frontiers in Pharmacology|October 16, 2018
Metronomic Four-Drug Regimen Has Anti-tumor Activity in Pediatric Low-Grade Glioma; The Results of a Phase II Clinical TrialArnauld Verschuur, Marie-Amélie Heng-Maillard, Philippe Dory-Lautrec, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 6, 2013
Results of a multicenter prospective study on the postoperative treatment of unilateral retinoblastoma after primary enucleationIsabelle Aerts, Xavier Sastre-Garau, Alexia Savignoni, et al.
European Journal of Cancer (Oxford, England : 1990)|January 10, 2024
METRO-PD1: Phase 1 study of nivolumab in combination with metronomic chemotherapy in children and adolescents with relapsing/refractory solid tumorsNicolas André, Marie Cécile Le Deley, Clémence Léguillette, et al.
European Radiology|September 11, 2025
Correction: Practical guidelines on imaging of retinoblastoma: a 2025 update on behalf of the European Retinoblastoma Imaging Collaboration and the European Retinoblastoma GroupLiesbeth Cardoen, Selma Sirin, Paolo Galluzzi, et al.
British Journal of Clinical Pharmacology|October 28, 2021
Pharmacokinetics of oral vinorelbine in French children with recurrent or progressive primary low-grade gliomaMourad Hamimed, Florence Gattacceca, Nicolas André, et al.
European Radiology|August 6, 2025
Practical guidelines on imaging of retinoblastoma: a 2025 update on behalf of the European Retinoblastoma Imaging Collaboration and the European Retinoblastoma GroupLiesbeth Cardoen, Selma Sirin, Paolo Galuzzi, et al.
Pageof 13

Showing results (51-60 of 123) with videos related to

Sort By:
Pageof 13
Human Molecular Genetics|May 27, 2014
The survival gene MED4 explains low penetrance retinoblastoma in patients with large RB1 deletionCatherine Dehainault, Alexandra Garancher, Laurent Castéra, et al.
European Journal of Medical Genetics|July 22, 2018
Correlation between RB1germline mutations and second primary malignancies in hereditary retinoblastoma patients treated with external beam radiotherapyAmélie Chaussade, Gaël Millot, Constance Wells, et al.
Pediatric Blood & Cancer|July 4, 2020
Tumor rupture in hepatoblastoma: A high risk factor?Morgane Pondrom, Daniele Pariente, Brenda Mallon, et al.
Frontiers in Pediatrics|June 9, 2023
A phase 1, first-in-child, multicenter study to evaluate the safety and efficacy of the oncolytic herpes virus talimogene laherparepvec in pediatric patients with advanced solid tumorsLucas Moreno, Pierre Teira, James M Croop, et al.
Frontiers in Pharmacology|October 16, 2018
Metronomic Four-Drug Regimen Has Anti-tumor Activity in Pediatric Low-Grade Glioma; The Results of a Phase II Clinical TrialArnauld Verschuur, Marie-Amélie Heng-Maillard, Philippe Dory-Lautrec, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 6, 2013
Results of a multicenter prospective study on the postoperative treatment of unilateral retinoblastoma after primary enucleationIsabelle Aerts, Xavier Sastre-Garau, Alexia Savignoni, et al.
European Journal of Cancer (Oxford, England : 1990)|January 10, 2024
METRO-PD1: Phase 1 study of nivolumab in combination with metronomic chemotherapy in children and adolescents with relapsing/refractory solid tumorsNicolas André, Marie Cécile Le Deley, Clémence Léguillette, et al.
European Radiology|September 11, 2025
Correction: Practical guidelines on imaging of retinoblastoma: a 2025 update on behalf of the European Retinoblastoma Imaging Collaboration and the European Retinoblastoma GroupLiesbeth Cardoen, Selma Sirin, Paolo Galluzzi, et al.
British Journal of Clinical Pharmacology|October 28, 2021
Pharmacokinetics of oral vinorelbine in French children with recurrent or progressive primary low-grade gliomaMourad Hamimed, Florence Gattacceca, Nicolas André, et al.
European Radiology|August 6, 2025
Practical guidelines on imaging of retinoblastoma: a 2025 update on behalf of the European Retinoblastoma Imaging Collaboration and the European Retinoblastoma GroupLiesbeth Cardoen, Selma Sirin, Paolo Galuzzi, et al.
Pageof 13